Status:
COMPLETED
Metoclopramide for Migraine: A Dose Finding Study
Lead Sponsor:
Montefiore Medical Center
Conditions:
Migraine
Eligibility:
All Genders
18-69 years
Phase:
PHASE3
Brief Summary
Metoclopramide is an effective intravenous treatment for acute migraine attacks, but we do not know the best dose to administer. This study compares three different doses of metoclorpamide.
Detailed Description
Patients with acute migraine attacks are eligible for enrollment if they present to the emergency department of Montefiore Medical Center. Pain scores are assessed at baseline and every 30 minutes for...
Eligibility Criteria
Inclusion
- acute migraine
Exclusion
- secondary cause of headache
- lumbar puncture
- allergy or intolerance to study medication
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
349 Patients enrolled
Trial Details
Trial ID
NCT00682734
Start Date
April 1 2008
End Date
March 1 2010
Last Update
May 31 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Medical Center
The Bronx, New York, United States, 10467